Global Artificial Organs Industry

Global Artificial Organs Industry

  • February 2020 •
  • 107 pages •
  • Report ID: 92544 •
  • Format: PDF
Artificial Organs market worldwide is projected to grow by US$11 Billion, driven by a compounded growth of 7.7%. Artificial Kidneys, one of the segments analyzed and sized in this study, displays the potential to grow at over 8.4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$14.6 Billion by the year 2025, Artificial Kidneys will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 8.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$497.8 Million to the region’s size and clout in the next 5 to 6 years. Over US$514.6 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Artificial Kidneys will reach a market size of US$1.2 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 7.4% over the next couple of years and add approximately US$1.9 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include, among others,
  • Abbott.
  • Abiomed Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Baxter International Inc.
  • F.Hoffmann-La Roche Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • HeartWare International Inc.
  • Jarvik Heart Inc.
  • Medtronic Inc.
  • Nikkiso Co. Ltd.
  • Nipro Corp.
  • SynCardia Systems LLC
  • Toray Medical Co., Ltd.
  • Xenios AG